| Breakdown | TTM | Jun 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 50.30M | 44.30M | 13.56M | 9.99M | 1.16M |
| Gross Profit | 30.34M | 25.46M | 8.15M | 5.18M | -195.16K |
| EBITDA | -3.54M | -67.81M | -11.84M | -4.87M | -2.64M |
| Net Income | -15.40M | -72.87M | -14.02M | -9.74M | -15.64M |
Balance Sheet | |||||
| Total Assets | 44.87T | 32.58M | 15.18M | 15.87M | 17.09M |
| Cash, Cash Equivalents and Short-Term Investments | 5.14T | 5.03M | 589.34K | 913.64K | 4.63M |
| Total Debt | 6.53T | 23.86M | 8.95M | 23.72M | 21.48M |
| Total Liabilities | 68.95T | 58.27M | 66.26M | 52.83M | 44.20M |
| Stockholders Equity | -26.60T | -25.07M | -50.85M | -36.88M | -27.10M |
Cash Flow | |||||
| Free Cash Flow | -825.51B | -18.57M | -8.39M | -50.07K | -5.10M |
| Operating Cash Flow | -3.71M | -18.14M | -7.55M | -50.07K | -4.71M |
| Investing Cash Flow | -2.25M | -115.62K | -841.36K | -204.10M | -2.80M |
| Financing Cash Flow | 20.48M | 11.74M | 8.36M | 205.09M | -24.19K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $38.88M | 21.25 | 1.40% | ― | 7.70% | -36.01% | |
49 Neutral | $33.64M | 0.71 | ― | ― | ― | ― | |
47 Neutral | $27.25M | -0.54 | ― | ― | -15.54% | 61.46% | |
44 Neutral | $104.40M | -6.76 | ― | ― | 3.42% | 93.90% | |
44 Neutral | $18.30M | -0.38 | -313.72% | ― | -39.75% | -89.61% | |
43 Neutral | $34.52M | -3.04 | -18.69% | ― | ― | ― |
On February 25, 2026, Roadzen Inc. entered into a Second Amendment with an institutional investor to revise a previously agreed Securities Purchase Agreement and junior convertible notes originally issued in November 2025. The amendment changes the first two installment dates on the November notes to April 21, 2026, and May 21, 2026, reflecting a rescheduling of the company’s near-term payment obligations under the notes.
The Second Amendment also grants the investor a right to participate in certain future financings undertaken by Roadzen before June 20, 2026, subject to specified conditions and limits. These changes adjust the company’s capital-raising framework and repayment timeline, potentially easing short-term liquidity pressures while deepening its relationship with the institutional investor and shaping dilution and financing options for existing stakeholders.
The most recent analyst rating on (RDZN) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Roadzen Inc stock, see the RDZN Stock Forecast page.
On January 19–20, 2026, Roadzen Inc. entered into a securities purchase agreement with an institutional investor and completed a registered public offering of junior convertible notes with an aggregate principal amount of up to $5,555,555, sold for gross proceeds of $5 million. The notes, bearing 14% annual interest and maturing on June 20, 2027, are convertible into ordinary shares at an initial price of $3.50, feature quarterly principal repayments, redemption and make-whole provisions, and strict beneficial-ownership caps, while also restricting Roadzen’s ability to incur additional debt or issue certain equity-linked securities; in parallel, the company amended junior convertible notes issued in November 2025 to add cross-default and covenant alignment, tightening creditor protections and potentially influencing its capital structure and financing flexibility going forward.
The most recent analyst rating on (RDZN) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Roadzen Inc stock, see the RDZN Stock Forecast page.